Metformin treatment in type 2 diabetes in pregnancy: an active controlled, parallel-group, randomized, open label study in patients with type 2 diabetes in pregnancy

Jahan Ara Ainuddin, Nasim Karim, Sidra Zaheer, Syed Sanwer Ali, Anjum Ara Hasan, Jahan Ara Ainuddin, Nasim Karim, Sidra Zaheer, Syed Sanwer Ali, Anjum Ara Hasan

Abstract

Aims: To assess the effect of metformin and to compare it with insulin treatment in patients with type 2 diabetes in pregnancy in terms of perinatal outcome, maternal complications, additional insulin requirement, and treatment acceptability.

Methods: In this randomized, open label study, 206 patients with type 2 diabetes in pregnancy who met the eligibility criteria were selected from the antenatal clinics. Insulin was added to metformin treatment when required, to maintain the target glycemic control. The patients were followed up till delivery. Maternal, and perinatal outcomes and pharmacotherapeutic characteristics were recorded on a proforma.

Results: Maternal characteristics were comparable in metformin and insulin treated group. 84.9% patients in metformin group required add-on insulin therapy at mean gestational age of 26.58 ± 3.85 weeks. Less maternal weight gain (P < 0.001) and pregnancy induced hypertension (P = 0.029) were observed in metformin treated group. Small for date babies were more in metformin group (P < 0.01). Neonatal hypoglycemia was significantly less and so was NICU stay of >24 hours in metformin group (P < 0.01). Significant reduction in cost of treatment was found in metformin group.

Conclusion: Metformin alone or with add-on insulin is an effective and cheap treatment option for patients with type 2 diabetes in pregnancy. This trial is registered with clinical trial registration number: Clinical trials.gov NCT01855763.

Figures

Figure 1
Figure 1
Flow diagram of study enrollment.

References

    1. Spellman C. W. Pathophysiology of type 2 diabetes: targeting islet cell dysfunction. The Journal of the American Osteopathic Association. 2010;110(3):S2–S7.
    1. Crawther C. A., Hiller J. E., Moss R. J., et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. The New England Journal of Medicine. 2005;352(24):2477–2486.
    1. Inzucchi S. E., Bergenstal R. M., Buse J. B., et al. Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the study of diabetes (EASD) Diabetologia. 2012;55(6):1577–1597.
    1. Hawthorne G. Metformin use and diabetic pregnancy—has its time come? Diabetic Medicine. 2006;23(3):223–227. doi: 10.1111/j.1464-5491.2006.01856.x.
    1. Caballero A. E., Delgado A., Aguilar-Salinas C. A., et al. The differential effects of metformin on markers of endothelial activation and inflammation in subjects with impaired glucose tolerance: a placebo-controlled, randomized clinical trial. Journal of Clinical Endocrinology and Metabolism. 2004;89(8):3943–3948. doi: 10.1210/jc.2004-0019.
    1. Kirpichikov D., McFarlane S. I., Sowers J. R. Metformin: an update. Annals of Internal Medicine. 2002;63:1879–1894.
    1. Rowan J. A., Hague W. M., Gao W., Battin M. R., Moore M. P. Metformin versus insulin for the treatment of gestational diabetes. The New England Journal of Medicine. 2008;358(19):2003–2015. doi: 10.1056/nejmoa0707193.
    1. Hague W. M., Davoren P. M., McIntyre D., Norris R., Xiaonian X., Charles B. G. Metformin crosses the placenta. Proceedings of the Medicine and Pregnancy; October 2003; Fremantle, Australia. Novo Nordisk;
    1. Glueck C. J., Goldenberg N., Pranicoff J., Loftspring M., Sieve L., Wang P. Height, weight, and motor—social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived on and continued metformin through pregnancy. Human Reproduction. 2004;19(6):1323–1330. doi: 10.1093/humrep/deh263.
    1. Harborne L., Fleming R., Lyall H., Norman J., Sattar N. Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome. The Lancet. 2003;361(9372):1894–1901. doi: 10.1016/s0140-6736(03)13493-9.
    1. Waheed S., Malik F. P., Mazhar S. B. Efficacy of metformin versus insulin in the management of pregnancy with diabetes. Journal of the College of Physicians and Surgeons Pakistan. 2013;23(12):866–869.
    1. Hughes R. C. E., Rowan J. A. Pregnancy in women with type 2 diabetes: who takes metformin and what is the outcome? Diabetic Medicine. 2006;23(3):318–322. doi: 10.1111/j.1464-5491.2006.01750.x.
    1. Ekpebegh C. O., Coetzee E. J., van der Merwe L., Levitt N. S. A 10-year retrospective analysis of pregnancy outcome in pregestational Type 2 diabetes: comparison of insulin and oral glucose-lowering agents. Diabetic Medicine. 2007;24(3):253–258. doi: 10.1111/j.1464-5491.2007.02053.x.
    1. Mohammed M. A., Abdelmonem A. M., Abdullah M. A., El Sayed A. A. Oral hypoglycemic as attractive alternative to insulin for the management of diabetes mellitus during pregnancy. Gynecology & Obstetrics. 2014;4(1, article 193) doi: 10.4172/2161-0932.1000193.
    1. Balani J., Hyer S. L., Rodin D. A., Shehata H. Pregnancy outcomes in women with gestational diabetes treated with metformin or insulin: a case-control study. Diabetic Medicine. 2009;26(8):798–802. doi: 10.1111/j.1464-5491.2009.02780.x.
    1. Spaulonci C. P., Bernardes L. S., Trindade T. C., Zugaib M., Francisco R. P. V. Randomized trial of metformin vs insulin in the management of gestational diabetes. American Journal of Obstetrics and Gynecology. 2013;209(1):34.e1–34.e7. doi: 10.1016/j.ajog.2013.03.022.
    1. Rai L., Meenakshi D., Kamath A. Metformin—a convenient alternative to insulin for Indian women with diabetes in pregnancy. Indian Journal of Medical Sciences. 2009;63(11):491–497. doi: 10.4103/0019-5359.58878.
    1. Hickman M. A., McBride R., Boggess K. A., Strauss R. Metformin compared with insulin in the treatment of pregnant women with overt diabetes: a randomized controlled trial. The American Journal of Perinatology. 2013;30(6):483–489. doi: 10.1055/s-0032-1326994.
    1. Tertti K., Ekblad U., Vahlberg T., Rönnemaa T. Comparison of metformin and insulin in the treatment of gestational diabetes: a retrospective, case-control study. Review of Diabetic Studies. 2008;5(2):95–101. doi: 10.1900/rds.2008.5.95.
    1. Ibrahim M. I., Hamdy A., Shafik A., Taha S., Anwar M., Faris M. The role of adding metformin in insulin-resistant diabetic pregnant women: a randomized controlled trial. Archives of Gynecology and Obstetrics. 2014;289(5):959–965. doi: 10.1007/s00404-013-3090-7.
    1. Viollet B., Guigas B., Garcia N. S., Leclerc J., Foretz M., Andreelli F. Cellular and molecular mechanisms of metformin: an overview. Clinical Science. 2012;122(6):253–270. doi: 10.1042/cs20110386.
    1. Swaminathan K., Howlett H. C. S., Campbell I. W. Metformin in diabetic pregnancy. Journal of the Royal College of Physicians of Edinburgh. 2009;39(1):10–14.
    1. Ijas H., Vaarasmaki M., Morinpaunen L. Metfromin should be considered in the treatment of gestational diabetes: a prospective randomized study. BJOG. 2010;10
    1. Hellmuth E., Damm P., Mølsted-Pedersen L. Oral hypoglycaemic agents in 118 diabetic pregnancies. Diabetic Medicine. 2000;17(7):507–511. doi: 10.1046/j.1464-5491.2000.00314.x.
    1. Moore L. E., Brieny G. I., Clokey D. Metformin and insulin in the management of gestational diabetes mellitus. The Journal of Reproductive Medicine. 2007;52:1011–1015.
    1. Coetzee E. J., Jackson W. P. U. Pregnancy in established non-insulin-dependent diabetics. A five-and-a-half year study at Groote Schuur Hospital. South African Medical Journal. 1980;58(20):795–802.
    1. Clinical Guidelines Task Force. Global Guidelines for Type 2 Diabetes. 2009.
    1. Ainuddin J., Karim N., Hasan A. A., Naqvi S. A. Metformin versus insulin treatment in gestational diabetes in pregnancy in a developing country. A randomized control trial. Diabetes Research and Clinical Practice. 2015;107(2):290–299. doi: 10.1016/j.diabres.2014.10.001.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다